MIDLINE Midline CT Midline IMPORTANT RISK INFORMATION MIDLINE Indications for Use: The Midline catheters are indicated for short or long term peripheral access to the peripheral venous system for selected intravenous therapies and blood sampling. (See Contraindications). For blood therapy it is recommended that a 4French or larger catheter be used. Contraindications: This catheter is not intended for any use other than that which is indicated. Do not implant catheter in thrombosed vessels. The presence of skin related problems around the insertion site (infection, phlebitis, scars, etc.) The presence of device related bacteremia or septicemia. History of mastectomy on insertion side. Previous history of venous/subclavian thrombosis or vascular surgical procedures at insertion site. Fever of unknown origin. The patient’s body size is insufficient to accommodate the size of the implanted device. The patient is known or is suspected to be allergic to materials contained in the device. Past irradiation of prospective insertion site. Local tissue factors will prevent proper device stabilization and/or access. A midline catheter placement is contraindicated for patients requiring any of the following: • Solutions with final glucose concentrations above 10 percent; • Solutions with protein concentrations above 5 percent; • Continuous infusion of vesicants. CT MIDLINE Indications for Use: The CT Midlines are indicated for Short-Term peripheral access to the peripheral venous system for selected intravenous therapies, blood sampling, and power injection of contrast media. The maximum recommended infusion rate varies by catheter French size and is printed on the catheter. Contraindications: This catheter is not intended for any use other than that which is indicated. Do not implant catheter in thrombosed vessels. The presence of skin related problems around the insertion site (infection, phlebitis, scars, etc.) The presence of device related bacteremia or septicemia. History of mastectomy on insertion side. Previous history of venous/subclavian thrombosis or vascular surgical procedures at insertion site. Fever of unknown origin. The patient’s body size is insufficient to accommodate the size of the implanted device. The patient is known or is suspected to be allergic to materials contained in the device. Past irradiation of prospective insertion site. Local tissue factors will prevent proper device stabilization and/or access. Do not use midline catheters for continuous vesican therapy, parenteral nutrition or infusates with an osmolarity greater than 900 mOsm/L. Refer to Instructions for Use provided with the product for complete instructions, warnings, and contraindications. Observe all instructions for use prior to using products. Failure to do so may result in patient complications. 58 Midline
RkJQdWJsaXNoZXIy MTYyNDM3Mw==